Ophthalmic Case Studies and Novel Approach

In a recent small-scale randomized controlled trial, the Oculeve Intranasal Lacrimal Neurostimulator (Allergan) was found to increase the production of aqueous tears and the secretion of goblet cells. This handheld device functions by administering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve within the nasal cavities. This innovative approach presents a potential new avenue for managing dry eye disease, which currently relies heavily on artificial tears and anti-inflammatory medications.

    Related Conference of Ophthalmic Case Studies and Novel Approach

    May 09-10, 2024

    7th International Eye and Vision Congress

    Barcelona, Spain
    May 16-17, 2024

    8th World Congress on Eye and Vision

    Rome, Italy
    May 23-24, 2024

    5th International Conference on Euro Ophthalmology and Eye Surgery

    Zurich, Switzerland
    June 13-14, 2024

    9th International Conference on Eye and Vision

    Barcelona, Spain
    June 20-21, 2024

    33rd International Conference on Insights in Ophthalmology

    Dublin, Ireland
    June 27-28, 2024

    5th World congress on Ophthalmology and Optometry

    London, UK
    September 12-13, 2024

    5th International Conference on Optometry

    Paris, France
    October 10-11, 2024

    34th World Congress on Ophthalmology and Optometry

    Madrid, Spain
    October 10-11, 2024

    10th Global Ophthalmology Meeting

    Madrid, Spain
    October 14-15, 2024

    5th International Conference on Ophthalmology and Optometry

    Paris, France
    October 17-18, 2024

    24th Global Ophthalmologists Annual Meeting

    London, UK
    December 12-13, 2024

    19th International Conference on Ophthalmology and Vision Science

    Rome, Italy

    Ophthalmic Case Studies and Novel Approach Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in